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Abstract
Background: Based on the clinical outcomes of patients with ST-segment elevation myocardial infarction 
(STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI), treated with primary percuta-
neous coronary intervention (pPCI), this study intended to assess mortality and major adverse cardiac and 
cerebrovascular event (MACCE) rates according to duration of pain-to-balloon (PTB) time and type of MI.
Methods: This is a retrospective cohort study based on the prospectively collected ORPKI registry which 
covers PCIs performed in Poland chosen between January 2014 and December 2017. Under assessment 
were 1,994 STEMI and 923 NSTEMI patients. Study endpoints included mortality and MACCE rates 
(in-hospital, 30-day, 12- and 36-month). Predictors of all-cause mortality in the overall group, STEMI 
and NSTEMI were assessed by multivariable analysis. 
Results: Kaplan-Meier survival curve analysis did not reveal significant differences between the 
STEMI and NSTEMI group for all-cause mortality or MACCE at the 36-month follow-up. While in 
the long PTB time group, MACCE rate was significantly greater in STEMI patients when compared to 
NSTEMI (p = 0.004). Among STEMI patients, the short, medium and long PTB time groups differed 
significantly in the rate of all-cause mortality (p = 0.006) and MACCE (p = 0.04) at 1,095 days of 
follow-up, which were the greatest in the long PTB time group. 
Conclusions: Before considering the length of PTB time, there were no statistically significant differ-
ences in mortality or MACCE frequency between the STEMI and NSTEMI group at 36-month follow-up.  
Longer PTB times are related to significantly greater mortality at the 36-month follow-up in the STEMI, 
but not in the NSTEMI group. (Cardiol J)
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The European Society of Cardiology guide-
lines recommend primary percutaneous coronary 
intervention (pPCI) as the preferred treatment for 
patients with acute myocardial infarction (AMI). 
In patients with ST-segment elevation myocardial 
infarction (STEMI), it is advocated that pPCI be 
performed ≤ 2 h from diagnosis, and at no longer 
than 24 h from diagnosis [1]. While the time of in-
vasive treatment in patients with non-ST-segment 
elevation myocardial infarction (NSTEMI) is less 
restrictive and mainly based on risk stratification. 
It depends on the initial risk stratification, and 
very high-risk patients should be treated with 
pPCI less than 2 h from diagnosis. For high-risk 
patients, this time may be prolonged to 24 h, while 
for intermediate-risk patients, an invasive strategy 
could be introduced even up to 72 h [2]. In the cur-
rent study, based on the local and distant clinical 
outcomes of patients with AMI treated with pPCI, 
the intention was to assess and compare clinical 
outcomes according to the duration of pain-to-bal-
loon (PTB) time, and its relationship with mortality, 
major adverse cardiac and cerebrovascular events 
(MACCE) in light of myocardial infarction type 
(STEMI vs. NSTEMI). The purpose of this was to 
evaluate potential factors that may have an effect 
on treatment results. Another important issue is 
the impact of selected factors on major endpoints 
such as mortality, depending on the follow-up 
period and type of AMI based on the analysis of 
a selected local population.
Therefore, the goal of the current study was 
to examine the relationship between clinical out-
comes and the duration of PTB time in STEMI 
and NSTEMI patients, as well as predictors of 
mortality. 
Methods
Study design, population setting  
and eligibility criteria
This is a retrospective cohort study based 
on the prospectively collected ORPKI registry, 
which covers almost all PCI procedures performed 
in Poland. This registry was described in previ-
ously published studies [3]. Patients were chosen 
between January 2014 and December 2017. All 
consecutive patients treated with PCI and with 
diagnosed AMI according to the current European 
guidelines were included in the present study [1, 2]. 
Then, data received from the ORPKI registry were 
matched with the data received from the National 
Health Fund. The procedure for merging data and 
its characteristics were described in a previously 
published work [4]. 
Study definitions 
Pain-to-balloon time was defined as the period 
from the occurrence of the earliest AMI symptoms 
to the first inflation of a catheter balloon within the 
culprit lesion. For the purpose of the current study, 
all of the included patients in the analysis were 
divided according to length of PTB time: patients 
with shorter PTB time than 3 h (short PTB time 
group), with the PTB time longer than 3 h but 
shorter than 12 h (medium PTB time group) and 
with the PTB time longer than 12 h but shorter 
than 24 h (long PTB time group). The overall group 
of AMI patients was also analysed according to the 
type of AMI: STEMI and NSTEMI. First contact-
-to-balloon time was defined as the duration from 
first medical contact of the patient with AMI to 
catheter balloon inflation in the culprit artery. 
Primary PCI protocol
The selection of interventional strategy and 
device usage were left to the discretion of the 
attending physician. Pharmacological treatment 
was ordered according to routinely recommended 
protocols [1, 2]. 
Study endpoints
All-cause mortality rate was distinguished 
among the primary study endpoints, which were 
assessed at selected time points: in-hospital, 30- 
-days, 12- and 36-months for death rates while 30-
-days, 12- and 36-months were for MACCE rates. 
Statistical analysis 
Categorical variables are presented as num-
bers and percentages. Continuous variables are 
expressed as means (standard deviation [SD]) or 
median (interquartile range [IQR]), where applica-
ble. Normality was assessed using the Shapiro-Wilk 
test. Equality of variance was assessed using the 
Levene’s test. Differences between the two groups 
were compared using the Student or Welch t-test 
depending on the equality of variances for normally 
distributed variables. The Mann-Whitney U test 
was used for non-normally distributed continuous 
variables. Categorical variables were compared 
via the Pearson c2 test or Fisher exact test if 20% 
of cells had an expected count of less than 5 (the 
Monte Carlo simulation for the Fisher test used 
tables of higher dimensions than 2 × 2). Multiple 
group comparisons were performed using analysis 
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of variance (ANOVA) or the Kruskal-Wallis test. 
The Tukey-Kramer HSD test or the Steel-Dwass 
method was used for post-hoc comparisons. In the 
case of categorical parameters and survival analy-
ses, the Benjamini-Hochberg procedure was used 
to adjust the p-value. Univariable and multivariable 
Cox proportional hazard models were applied to 
identify predictors of MACCE and death. The set 
of factors in the adjusted model included: time of 
day, type of MI, age, smoking status, hyperten-
sion, Killip class grade, gender, diabetes, kidney 
disease, prior stroke, MI and/or PCI, cardiac arrest 
at baseline, chronic obstructive pulmonary disease, 
treatment with acetylsalicylic acid at baseline as 
well as Thrombolysis in Myocardial Infarction 
(TIMI) flow grade before and after PCI. All statisti-
cal analyses were performed with JMP®, Version 
14.2.0 (SAS Institute INC., Cary, NC, USA). All sta-
tistical tests were two-sided, the level of p < 0.05 
was considered statistically significant.
Results
Study population 
The present study included 1,994 patients 
with STEMI and 923 patients with NSTEMI, thus 
a total of 2,917 consecutive patients admitted to 
the hospital with AMI and treated with pPCI. All 
patients were divided into three groups according 
to the duration of PTB time, as described above. 
In addition, patients were analysed depending on 
the type of infarction in the STEMI and NSTEMI 
patient groups. When considering the STEMI group 
and PTB times, there where 900 (45.1%) patients in 
the first, 949 (47.6%) patients in the second and 145 
(7.3%) patients in the third group. In the NSTEMI 
group, there were 100 (10.8%) in the first group, 502 
(54.4%) in the second and 321 (34.8%) in the third 
one. When considering the overall group of patients 
with AMI, the short, medium and long PTB time 
groups differed significantly in the rate of all-cause 
mortality (p = 0.04), but not MACCE (p = 0.88) at 
1,095 days of the follow-up period (Fig. 1A, B). The 
mortality rate was greatest in the long PTB time 
group compared to those with medium and short 
PTB times (Fig. 1A). Significant predictors of all-
cause mortality at selected time points (in-hospital, 
30-day, 12-month and 36-month), assessed by mul-
tivariable analysis, are presented in Figure 2A–D.
STEMI vs. NSTEMI
General characteristics. When comparing 
mean age, patients in NSTEMI group were sig-
nificantly older than in the STEMI group (67.3 ± 
± 12.2 vs. 65.3 ± 12.1, p < 0.05). Patients in the 
NSTEMI group suffered more often from kidney 
failure (4% vs. 2.2%, p < 0.05) and arterial hyper-
tension (67.6% vs. 61.5%, p < 0.05). These and 
other indices are presented in Table 1. 
Procedural indices. Patients from the STEMI 
group were significantly more frequently treated 
from femoral access and less from radial in compari-
son to the NSTEMI group (p < 0.05). These and 
other procedural indices are presented in Table 2. 
Study endpoints. In-hospital mortality (7% 
vs. 3.6%, p < 0.05) and 30-day mortality (7.7% vs. 
5.1%, p < 0.05) were significantly greater among 
STEMI patients compared to NSTEMI, and at the 
following time points (12-month and 36-month 
mortality), they did not differ significantly (Table 3). 
Kaplan-Meier survival curve analysis did not reveal 
significant differences between the STEMI and 
NSTEMI groups in all-cause mortality (p = 0.64) 
or MACCE (p = 0.17) at 36 months of follow-up.  
Pain-to-balloon times. When considering 
the short PTB time group, Kaplan-Meier survival 
curves analysis did not reveal significant differ-
ences between the STEMI and NSTEMI groups 
at 1,095 days of follow-up in all-cause mortality 
(p = 0.62) or MACCE (p = 0.28) rates (Fig. 3A, B). 
Similarly, in the medium PTB time group, Ka-
plan-Meier survival curves analysis did not show 
significant differences between the STEMI and 
NSTEMI groups at 1,095 days of follow-up in all-
cause mortality (p = 0.14) or MACCE (p = 0.86) 
rates (Fig. 3C, D). While in the long PTB time 
group, Kaplan-Meier survival curve analysis did 
not demonstrate significant differences at 1095 
days of follow-up in all-cause mortality (p = 0.18), 
however, it was significantly greater in STEMI 
patients when compared to NSTEMI for MACCE 
(p = 0.004) rates (Fig. 3E, F). 
Pain-to-balloon time in STEMI
General characteristics. When considering 
PTB times, patients from the long PTB time group 
were significantly older (p < 0.001) and were less 
often males (p = 0.006), smokers (p = 0.01), while 
they were found to have an incidence of prior stroke 
(p = 0.04) and MI (p = 0.02) more often. These 
and other indices are presented in Table 1. 
Procedural indices. Patients from the short 
PTB time group presented single-vessel disease 
(SVD) significantly more often, while multi-vessel 
disease (MVD) was less frequent in comparison 
to patients from the medium and long PTB time 
groups (p < 0.001). These and other procedural 
indices are presented in Table 2. 
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Figure 1. Selected study endpoints presented as Kaplan-Meier survival curves compared in the ST-segment elevation 
myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) groups according to 
the duration of pain-to-balloon time; A. All-cause mortality for 1,095 days of follow-up in patients with pain-to-balloon 
time shorter than 3 h; B. Major adverse cardiac and cerebrovascular events (MACCE) incidence for 1,095 days of 
follow-up in patients with pain-to-balloon time shorter than 3 h; C. All-cause mortality for 1,095 days of follow-up in 
patients with pain-to-balloon time longer than 3 h but shorter than 12 h; D. MACCE incidence for 1,095 days of follow-
up in patients with pain-to-balloon time longer than 3 h but shorter than 12 h; E. All-cause mortality for 1,095 days of 
follow-up in patients with pain-to-balloon time longer than 12 h but shorter than 24 h; F. MACCE incidence for 1,095 
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Study endpoints. The 30-day (p = 0.025), 
12-month (p = 0.019) and 36-month (p = 0.003) 
mortality rates were greatest among the long PTB 
time group compared to the medium and short 
PTB time groups (Table 3). The 30-day (p = 0.001) 
MACCE frequency was significantly higher in 
the long PTB time group in comparison to others 
(Table 3). When considering the STEMI group of 
patients, the short, medium and long PTB time 
groups significantly differed in the rate of all-cause 
mortality (p = 0.006) and MACCE (p = 0.04) at 
1,095 days of the follow-up period, which was the 
greatest in the long PTB time group compared to 
the medium and short ones (Fig. 1A, B). Signifi-
cant predictors of all-cause mortality at selected 
time points (in-hospital, 30-day, 12-month and 
36-month) assessed by multivariable analysis are 
presented in Figure 4A–D.
Pain-to-balloon time in NSTEMI
General characteristics. General character-
istics are presented in Table 1. 
Procedural indices. Radial access was sig-
nificantly more frequently used in the long PTB 
time group when compared to others, while femoral 
access was implemented less often (p < 0.001). 
Patients with SVD occurred significantly more 
frequently in the short PTB time group, while 
MVD patients were most present in the long PTB 
time group (p = 0.03). These and other procedural 
indices are presented in Table 2. 
Study endpoints. There were no significant 
differences in all-cause mortality or MACCE rates 
between all of the three assessed groups at all fol-
low-up time points (Table 3). Using Kaplan-Meier 
survival curves analysis, it was confirmed that 
there is no significant difference in the frequency 
of all-cause mortality (p = 0.86) and MACCE 
(p = 0.53) rates between short, medium and long 
PTB time groups (Fig. 3E, F). Significant predic-
tors of all-cause mortality at selected time points 
(in-hospital, 30-day, 12-month and 36-month) as-
sessed by multivariable analysis are presented in 
Figure 5A–D. 
Predictors of all-cause mortality 
Overall group. Among significant positive 
predictors of all-cause in-hospital mortality it was 
found that age, diabetes, TIMI flow grade after PCI, 
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Figure 2. Predictors of all-cause mortality assessed by multivariable analysis in the overall group of patients — acute 
myocardial infarction; A. In-hospital; B. 30-day; C. 12-month; D. 36-month; CI — confidence interval; HR — hazard 
ratio; LM — left main coronary artery; MVD — multi-vessel disease; SVD — single-vessel disease; PCI — percutane-
ous coronary intervention; TIMI — Thrombolysis in Myocardial Infarction.
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left main coronary artery (LMCA) involvement, while 
among the negative predictors it was treatment with 
unfractionated heparin (Fig. 2A). At 30-day follow-up, 
among positive predictors of all-cause mortality it was 
confirmed that age, TIMI grade flow after PCI, cardiac 
arrest and Killip class grade before PCI (Fig. 2B). At 
12-month follow-up, age, TIMI flow grade after PCI, 
cardiac arrest, Killip class grade before PCI, MVD ± 
± LMCA involvement were found to be significant 
predictors of all-cause mortality, while treatment with 
unfractionated heparin was a negative predictor (Fig. 
2C). Among significant positive predictors of all-cause 
mortality at 36-month follow-up there were age, TIMI 
flow grade after PCI, cardiac arrest, Killip class grade 
before PCI and MVD ± LMCA involvement (Fig. 2D). 
STEMI. Confirmed herein, was age, cardiac 
arrest, Killip class grade before PCI and MVD ± 
± LMCA involvement being among significant 
positive predictors of all-cause in-hospital mortal-
ity, while treatment with unfractionated heparin 
was among negative predictors (Fig. 4A). Among 
significant positive predictors of all-cause mortality 
found at 30-day follow-up was age, cardiac arrest 
and Killip-class grade (Fig. 4B). While at 12-month 
follow-up, age, TIMI flow grade after PCI, cardiac 
arrest and Killip class grade were confirmed as 
significant positive predictors of all-cause mortal-
ity, and treatment with unfractionated heparin was 
found to be negative predictor (Fig. 4C). Among 
significant positive predictors of all-cause mortality 
at 36-month follow-up age, TIMI flow grade after 
PCI, cardiac arrest and Killip class grade before 
PCI were confirmed (Fig. 4D). 
NSTEMI. Among significant positive predic-
tors of in-hospital all-cause mortality confirmed 
age, TIMI flow grade after PCI and Killip class 
grade before PCI were confirmed (Fig. 5A). At 
30-day follow-up, age, cardiac arrest and TIMI flow 
grade after PCI as positive predictors of all-cause 
mortality were confirmed, while among negative 
predictors was the smoking habit Age, cardiac ar-
rest and MVD ± LMCA involvement were found 
to be significant predictors of all-cause mortality at 
12-month follow-up (Fig. 5C), while at 36-month: 
age, TIMI flow grade after PCI, cardiac arrest and 
MVD ± LMCA involvement (Fig. 5D). Among neg-
ative predictors of all-cause mortality at 36-month 
follow-up smoking habit was found (Fig. 5D).
Discussion
This study demonstrated that in the overall 
group of patients there were no significant differ-
ences in all-cause mortality between the STEMI 
8 www.cardiologyjournal.org
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Figure 3. Selected study endpoints presented as Kaplan-Meier survival curves compared in short, medium and 
long pain-to-balloon time groups according to the type of myocardial infarction (acute myocardial infarction [AMI] 
— overall group, ST-segment elevation myocardial infarction [STEMI] and non-ST-segment elevation myocardial 
infarction [NSTEMI]); A. All-cause mortality for 1,095 days of follow-up in the AMI group; B. Major adverse cardiac 
and cerebrovascular events (MACCE) incidence for 1,095 days of follow-up in the AMI group; C. All-cause mortality 
for 1,095 days of follow-up in the STEMI group; D. MACCE incidence for 1,095 days of follow-up in the STEMI group; 
E. All-cause mortality for 1,095 days of follow-up in the NSTEMI group; F. MACCE incidence for 1,095 days of follow-
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Figure 4. Predictors of all-cause mortality assessed by multivariable analysis in the ST-segment elevation myocardial 
infarction (STEMI) group; A. In-hospital; B. 30-day; C. 12-month; D. 36-month. CI — confidence interval; HR — hazard 
ratio; LM — left main coronary artery; MVD — multi-vessel disease; SVD — single-vessel disease; PCI — percutane-
ous coronary intervention; TIMI — Thrombolysis in Myocardial Infarction.
Figure 5. Predictors of all-cause mortality assessed by multivariable analysis in the non-ST-segment elevation myo-
cardial infarction (NSTEMI) group; A. In-hospital; B. 30-day; C. 12-month; D. 36-month. CI — confidence interval; 
HR — hazard ratio; LM — left main coronary artery; MVD — multi-vessel disease; SVD — single-vessel disease; 
PCI — percutaneous coronary intervention; TIMI — Thrombolysis in Myocardial Infarction.
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and NSTEMI groups at the 36-month follow-up. 
While there were no statistical differences between 
these groups when comparing the short and me-
dium PTB time groups, the MACCE rate, but not 
mortality, was significantly greater in the STEMI 
group when compared to NSTEMI for the long PTB 
time group at the 36-month follow-up. Mortality 
rate at 36 months was significantly greater in the 
long PTB time group compared to the others in 
the overall AMI and STEMI groups, nevertheless, 
it remained non-significant for NSTEMI. MACCE 
rate was also significantly greater in the long PTB 
time group compared to others in STEMI patients, 
but not in the NSTEMI and overall AMI groups at 
36-month follow-up. There were no clear differ-
ences between individual types of MIs in terms of 
mortality predictors, although the results indicate 
that the severity of coronary artery atherosclerosis 
(MVD/LMCA vs. SVD/none) was significant for 
the NSTEMI and overall AMI groups, but not for 
STEMI patients. Other predisposing factors for 
increased mortality were similar irrespective of 
the type of infarction or follow-up, and included 
age, clinical image at admission as well as arterial 
patency before and after surgery. 
It is well established that the shorter the 
duration of ischemia, the smaller the myocardial 
damage and better long-term prognosis and sur-
vival. There are many different time points in the 
guidelines proposed by the European Society of 
Cardiology. The door-to-balloon (DTB) time is 
a well-established predictor of survival [1, 2]. All 
of the available measures are taken to shorten the 
DTB time and it seems that the field in which we 
still can make progress to reduce ischemia is PTB 
time. Comparing DTB time to the onset of symp-
toms, and further to balloon time, Park et al. [5] 
revealed that the median PTB time was 3.2 h and 
it was associated with increased 1-year mortality. 
In our study, 1-year mortality was remarkably 
higher in the STEMI and long PTB time groups. 
Evaluating symptom to balloon time, Alsamara et 
al. [6] noted that its longer duration was associ-
ated with worse left ventricular ejection fraction 
(LVEF), which could be responsible for worse fu-
ture clinical outcomes. In the present study, longer 
PTB time was related to higher 30-day mortality 
in the STEMI group, and inversely, mortality ex-
perienced a decrease along with the longer delay 
in PTB time in the NSTEMI group. Considering 
long-term mortality, longer PTB time was asso-
ciated with worse outcomes among the STEMI 
group, no such significant differences were noted 
among NSTEMI patients. Chen et al. [7] verified 
that DTB time < 60 min is associated with better 
blood flow assessed by the TIMI flow grade scale in 
the infarct-related artery and lower 30-day mortal-
ity rates. In the current work, TIMI flow grade 3 
after the procedure was an independent predictor 
of long- and short-term mortality in all groups of 
patients, and it was also related with shorter PTB 
time. Halkin et al. [8] have created the CADILLAC 
score for predicting mortality after PCI for patients 
with AMI. Among featured parameters, we may 
find: Killip class 2–3, final TIMI flow of 0–2, age 
> 65 years, three-vessel disease, anemia, renal 
insufficiency and baseline LVEF < 40%. Another 
study comparing short- and long-term outcomes 
for patients after PCI due to MI showed that the 
STEMI group was associated with a higher risk of 
short-term mortality, while NSTEMI was associa-
ted with a higher risk of long-term mortality [9]. 
Results herein, confirmed higher in-hospital and 
30-day mortality rate among the STEMI group, 
but what is of more importance, it was indicated 
that the highest mortality rate was among patients 
with the longest PTB time > 12–24 h. De Luca et 
al. [10] created the Zwolle Risk Score for STEMI 
patients, which includes 6 independent predictors 
of 30-day mortality among patients with STEMI 
and allows  estimating short-term mortality risk. 
In the present study, 5 of them were confirmedas 
significant predictors of in-hospital and 30-day 
mortality. Focusing on the STEMI group with the 
shortest PTB time of < 3 h and having the best 
short-term outcomes, it was noted that a major-
ity of patients had SVD, were in the Killip class 
1 and had TIMI flow 3 after PCI, consequently, 
finding themselves at lower risk according to the 
Zwolle Risk Score [10]. In further analysis, TIMI 
flow after PCI < 3 was a significant predictor of 
mortality in almost all groups of patients and time 
points of follow-up, which is consistent with the 
results obtained in the study by Karwowski et al. 
[11] who noted that mortality rates in patients with 
final TIMI 0–1 and 2 scores were not significantly 
different, and only achieving final TIMI 3 in the in-
farct-related artery improves outcomes in NSTEMI 
patients. LVEF is one of the most commonly noted 
in-hospital and 1-year mortality predictors, how-
ever, we were not able to assess it due to a lack of 
this data in the analyzed database [12, 13]. Killip 
class scale remains in close correlation with LVEF. 
In the present study, Killip class 2–4 tended to be 
a strong positive predictor of adverse outcomes 
in the STEMI as well as NSTEMI groups. Post-
procedural TIMI flow > 3 as a negative predictor 
of death is mentioned by De Luca et al. [10] and 
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Karwowski et al. [11]. Garadah et al. [14] indicated 
higher in-hospital mortality among STEMI com-
pared to NSTEMI patients, which corresponds with 
the present results. Interestingly, in the current 
observation, in-hospital mortality rate increased 
with longer PTB time in the STEMI group while 
it decreased in the NSTEMI group. This may sug-
gest that proper preparation of patients admitted 
with NSTEMI could prevent post-PCI complica-
tions such as pulmonary edema, aggravation of 
coexisting anemia or contrast induced nephropathy. 
Inversely, in the STEMI group, prolongation of 
PTB time is responsible for the worst outcomes. In 
a 1-year observation, Pocock et al. [13] noted high-
er overall mortality rate among NSTEMI patients 
compared to the STEMI group. Analogous results 
were obtained by Chan et al. [9], but noting that 
patients in the NSTEMI group were older and had 
a greater burden of comorbidities. In the present 
analysis, after 1 year of follow-up, the difference 
in mortality rate among the STEMI and NSTEMI 
groups slowly decreased (11.6% vs. 10.2%) and 
the risk of death at 3-year follow-up was practically 
equal in both groups (15.4 vs. 15.1). 
In 1 paper published to date, a benefit in 1-year 
follow-up in terms of mortality and myocardial re-
infarction of complete revascularization in patients 
with MVD and STEMI, as well as NSTEMI over 
the incomplete revascularization was demonstrated 
[15]. However, in the present study, the number 
of patients who underwent incomplete revascu-
larization was very small due to the fact that all 
patients, except for a few cases, had concurrent 
or staged complete revascularization of significant 
stenosis, which were confirmed by angiography 
or additional imaging (intravascular ultrasound) 
and functional evaluation (fractional flow reserve) 
of the coronary circulation. Patients who did not 
undergo complete revascularization, despite the 
presence of significant stenosis, were few and 
belonged to the group of very high-risk patients, 
e.g. palliative patients, with many internal diseases, 
chronically immobilized (patients after a stroke), 
planned to undergo surgical treatment or were at 
high risk of bleeding.
Limitations of the study
The main limitations of the study are the lack 
of a range of data that could have had significant 
impact on the results of calculations, which was 
conditioned by the nature of the registry being 
analyzed. The missing data firstly included LVEF, 
biochemical indicators such as creatinine or myo-
cardial damage indicators, as well as data on the 
type of stents and techniques used during pPCI.
Conclusions
Before considering the duration of PTB time, 
no statistically significant differences were ob-
served in mortality or MACCE frequency between 
the STEMI and NSTEMI groups at 36-month 
follow-up. Mortality rate at 36 months was sig-
nificantly greater in the long PTB time group 
compared to the other groups in the overall AMI 
group and STEMI group, while it remained non-
-significant for NSTEMI. The MACCE rate was 
also significantly greater in the long PTB time 
group compared to others in STEMI patients, but 
not in the NSTEMI and overall AMI groups during 
36-month follow-up. Based on the available data 
in the current analysis, there are no clear differ-
ences between individual types of MIs in terms of 
mortality predictors, although the results indicate 
that the severity and extent of atherosclerosis dis-
semination in the coronary arteries was significant 
for the NSTEMI and overall AMI groups, but not 
for STEMI patients. Other predisposing factors of 
increased mortality were similar irrespective of 
the type of infarction and follow-up, and included 
age, clinical image at admission, as well as arterial 
patency before and after surgery. 
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